L-fucose

By Targets:	Endogenous Metabolite (8) Isotope-Labeled Compounds (4) Parasite (5)
By Research Areas:	Cancer (1) Infection (5) Metabolic Disease (7)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N1480

(-)-Fucose 6-Desoxygalactose; L-(-)-fucose; L-Galactomethylose	Endogenous Metabolite Parasite	Infection Metabolic Disease
(-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interactions. (-)-Fucose is orally active, inhibits CL11-induced inflammatory response in kidney and tumor growth .

HY-N1480S

*(-)-Fucose-13C* 6-Desoxygalactose-¹³C; L-(-)-fucose-¹³C; L-Galactomethylose-¹³C	Isotope-Labeled Compounds Endogenous Metabolite Parasite	Infection Metabolic Disease
(-)-Fucose- ¹³C is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[1]

HY-N1480S1

*(-)-Fucose-13C-1* 6-Desoxygalactose-¹³C-1; L-(-)-fucose-¹³C-1; L-Galactomethylose-¹³C-1	Isotope-Labeled Compounds Endogenous Metabolite Parasite	Infection Metabolic Disease
(-)-Fucose- ¹³C-1 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

HY-N1480S2

*(-)-Fucose-13C-2* 6-Desoxygalactose-¹³C-2; L-(-)-fucose-¹³C-2; L-Galactomethylose-¹³C-2	Isotope-Labeled Compounds Endogenous Metabolite Parasite	Infection Metabolic Disease
(-)-Fucose- ¹³C-2 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

HY-N1480S3

*(-)-Fucose-13C-3* 6-Desoxygalactose-¹³C-3; L-(-)-fucose-¹³C-3; L-Galactomethylose-¹³C-3	Isotope-Labeled Compounds Endogenous Metabolite Parasite	Infection Metabolic Disease
(-)-Fucose- ¹³C-3 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

HY-116705

2-Deoxy-2-fluoro-L-fucose	Others	Cancer
2-Deoxy-2-fluoro-L-fucose, an L-fucose analog, is a fucosylation inhibitor. 2-Deoxy-2-fluoro-L-fucose inhibits de novo synthesis of GDP-fucose in mammalian cells. Fucosylation is a relatively well-defined biomarker for progression in many human cancers; for example, pancreatic and hepatocellular carcinoma .

HY-N10530

Lactodifucotetraose Difucosyllactose ; 2′,3-Difucosyllactose	Others	Others
Lactodifucotetraose (Difucosyllactose) is a tetrasaccharide isolated from human milk. Lactodifucotetraose constitutes of D-glucose, 1 D-galactose, and L-fucose .

HY-E70064

alpha-1,3-Fucosyltransferase (α1,3FucT)	Endogenous Metabolite	Others
alpha-1,3-Fucosyltransferase (α1,3FucT) catalyzes the transfer of L-fucose moiety from guanosine diphosphate-beta-L-fucose (GDP-Fuc) to acceptor sugars. alpha-1,3-Fucosyltransferase (α1,3FucT) is often used in biochemical studies, and it can be used to form fucoglycoconjugates .

HY-134433

GDP-L-fucose	Endogenous Metabolite	Metabolic Disease
GDP-L-fucose is a nucleotide sugar that is a key substrate for the biosynthesis of fucose oligosaccharides, providing the fucose moiety for the oligosaccharides.The formation of GDP-L-fucose occurs through two pathways, the major ab initio metabolic pathway and the minor remedial metabolic pathway .

HY-134433A

*GDP-L-fucose* disodium**	Endogenous Metabolite	Metabolic Disease
GDP-L-fucose disodium is a nucleotide sugar that is a key substrate for the biosynthesis of fucose oligosaccharides. GDP-L-fucose disodium provides the fucose moiety for the oligosaccharides. The formation of GDP-L-fucose disodium occurs through two pathways, the major de novo metabolic pathway and the minor remedial metabolic pathway .

Cat. No.	Product Name	Type

HY-E70064

alpha-1,3-Fucosyltransferase (α1,3FucT)	Biochemical Assay Reagents
alpha-1,3-Fucosyltransferase (α1,3FucT) catalyzes the transfer of L-fucose moiety from guanosine diphosphate-beta-L-fucose (GDP-Fuc) to acceptor sugars. alpha-1,3-Fucosyltransferase (α1,3FucT) is often used in biochemical studies, and it can be used to form fucoglycoconjugates .

HY-E70026

*L-fucokinase/GDP-fucose* pyrophos-phorylase (FKP)**	Biochemical Assay Reagents
L-fucokinase/GDP-fucose pyrophos-phorylase (FKP) is an enzyme that catalyzes the chemical reaction. L-fucokinase/GDP-fucose pyrophos-phorylase (FKP) has substrate of L-fucose. L-fucokinase/GDP-fucose pyrophos-phorylase (FKP) induces L-fucose phosphorylation to form L-fucose-L-phosphate .

HY-134433A

*GDP-L-fucose* disodium**	Biochemical Assay Reagents
GDP-L-fucose disodium is a nucleotide sugar that is a key substrate for the biosynthesis of fucose oligosaccharides. GDP-L-fucose disodium provides the fucose moiety for the oligosaccharides. The formation of GDP-L-fucose disodium occurs through two pathways, the major de novo metabolic pathway and the minor remedial metabolic pathway .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N1480

(-)-Fucose 6-Desoxygalactose; L-(-)-fucose; L-Galactomethylose	Structural Classification Natural Products Human Gut Microbiota Metabolites Microorganisms Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite Parasite
(-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interactions. (-)-Fucose is orally active, inhibits CL11-induced inflammatory response in kidney and tumor growth .

HY-N10530

Lactodifucotetraose Difucosyllactose ; 2′,3-Difucosyllactose	Natural Products Polysaccharides Classification of Application Fields Animals Other Diseases Disease Research Fields Saccharides	Others
Lactodifucotetraose (Difucosyllactose) is a tetrasaccharide isolated from human milk. Lactodifucotetraose constitutes of D-glucose, 1 D-galactose, and L-fucose .

HY-134433

GDP-L-fucose	Structural Classification Natural Products Human Gut Microbiota Metabolites Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
GDP-L-fucose is a nucleotide sugar that is a key substrate for the biosynthesis of fucose oligosaccharides, providing the fucose moiety for the oligosaccharides.The formation of GDP-L-fucose occurs through two pathways, the major ab initio metabolic pathway and the minor remedial metabolic pathway .

HY-134433A

*GDP-L-fucose* disodium**	Structural Classification Natural Products Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
GDP-L-fucose disodium is a nucleotide sugar that is a key substrate for the biosynthesis of fucose oligosaccharides. GDP-L-fucose disodium provides the fucose moiety for the oligosaccharides. The formation of GDP-L-fucose disodium occurs through two pathways, the major de novo metabolic pathway and the minor remedial metabolic pathway .

Species:	Human (1)
Tag:	His (2) Tag Free (1) Flag (1)
Source:	E. coli (3)

Cat. No.	Compare	Product Name	Species	Source

HY-P702109

	dai Protein, Aeribacillus pallidus dai; L-fucose isomerase; FucIase; 6-deoxy-L-galactose isomerase	Others	E. coli
	Dai protein serves as a catalyst in the biochemical conversion of the aldose L-fucose into its corresponding ketose, L-fuculose. This enzymatic activity highlights Dai's role in facilitating the transformation of specific sugar molecules, contributing to the diverse metabolic pathways where such conversions play essential roles. dai Protein, Aeribacillus pallidus is the recombinant dai protein, expressed by E. coli , with tag free. The total length of dai Protein, Aeribacillus pallidus is 595 a.a., .

HY-P702110

	dai Protein, Aeribacillus pallidus (FLAG, His) dai; L-fucose isomerase; FucIase; 6-deoxy-L-galactose isomerase	Others	E. coli
	Dai protein serves as a catalyst in the biochemical conversion of the aldose L-fucose into its corresponding ketose, L-fuculose. This enzymatic activity highlights Dai's role in facilitating the transformation of specific sugar molecules, contributing to the diverse metabolic pathways where such conversions play essential roles. dai Protein, Aeribacillus pallidus (FLAG, His) is the recombinant dai protein, expressed by E. coli , with N-6*His, N-Flag labeled tag. The total length of dai Protein, Aeribacillus pallidus (FLAG, His) is 595 a.a., .

HY-P71390

	TSTA3 Protein, Human (His) GDP-L-fucose Synthase; GDP-4-Keto-6-Deoxy-D-Mannose-3; 5-Epimerase-4-Reductase; Protein FX; Red Cell NADP(H)-Binding Protein; Short-Chain Dehydrogenase/Reductase Family 4E Member 1; TSTA3; SDR4E1	Human	E. coli
	The TSTA3 protein plays a key role in catalyzing the two-step NADP-dependent conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose. The process involves successive epimerase and reductase reactions, ultimately leading to the biosynthesis of GDP-fucose. TSTA3 Protein, Human (His) is the recombinant human-derived TSTA3 protein, expressed by E. coli , with C-6*His labeled tag. The total length of TSTA3 Protein, Human (His) is 321 a.a., with molecular weight of ~40.0 kDa.


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-N1480S

*(-)-Fucose-13C*
(-)-Fucose- ¹³C is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[1]

HY-N1480S1

*(-)-Fucose-13C-1*
(-)-Fucose- ¹³C-1 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

HY-N1480S2

*(-)-Fucose-13C-2*
(-)-Fucose- ¹³C-2 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

HY-N1480S3

*(-)-Fucose-13C-3*
(-)-Fucose- ¹³C-3 is the ¹³C labeled (-)-Fucose. (-)-Fucose is classified as a member of the hexoses, plays a role in A and B blood group antigen substructure determination, selectin-mediated leukocyte-endothelial adhesion, and host-microbe interacti[

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Biochemical Assay Reagents

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Name
Email *

	Sorry, but the email address you supplied was invalid.

L-fucose

Inhibitors & Agonists

Biochemical Assay Reagents

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Natural
Products